LATEST NEWS

NBTXR3 nanoparticle with immunoradiation improves survival and generates long-term anti-tumor memory in an anti-PD1 resistant murine lung cancer model

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.